The dried or fresh mature fruits of Emblica officinalis Gaertn. are specified source of drug named ‘Aamla’. It is commonly known as Indian gooseberry or Amla. E. officinalis is an important medicinal plant in Indian System of Medicines (Ayurveda, Unani and Siddha). It is one of the most important ingredient in Triphala {an Ayurvedic herbal rasayana formula consisting of equal parts of three myrobalans, taken without seed in Amalaki (Emblica officinalis), Bibhitaki (Terminalia bellirica) and Haritaki (Terminalia chebula) }. It is prescribed for improving digestion and assimilation. The drug is also used in famous ayurvedic preparation Chyawanprash which is used for cough, bronchitis, haemoptysis, tuberculosis and as rejuvenating tonic. The drug is highly regarded for varied therapeutic values and enjoys the official status in Unani Pharmacopoeia of India, Ayurvedic Pharmacopoeia of India, Siddha Pharmacopoeia of India, Homoeopathic Pharmacopoeia of India and Indian Pharmacopoeia. Pharmacopoeial monographs on the drug are regulatory standards and mandatory for compliance to ensure the quality, safety and efficacy of the drug. This communication reviews the pharmacopoeial monographs and analytical parameters specified in different pharmacopoeial and non-pharmacopoeial publications with a view on harmonization aspect of quality specifications of E. officinalis Gaertn.